These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23097883)

  • 1. [Selection criteria decisive in hepatocellular carcinoma].
    Söderdahl G; Eilard MS; Rizell M
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
    Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?
    Yao FY; Roberts JP
    Liver Transpl; 2004 Jul; 10(7):919-21. PubMed ID: 15237378
    [No Abstract]   [Full Text] [Related]  

  • 4. Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.
    Lee SG; Moon DB; Shin H; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
    Transplant Proc; 2012 Mar; 44(2):520-2. PubMed ID: 22410060
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
    Roayaie S; Llovet JM
    Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocellular carcinoma and liver transplantation.
    Washburn K; Halff G
    Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma: the Hangzhou experience.
    Busuttil RW
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):235-6. PubMed ID: 18522877
    [No Abstract]   [Full Text] [Related]  

  • 9. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver transplantation for hepatocellular carcinoma].
    Decaens T; Hurtova M; Duvoux C
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):61-9. PubMed ID: 19108968
    [No Abstract]   [Full Text] [Related]  

  • 11. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
    Vining CC; Ecker BL; Abt PL; Olthoff KM
    Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
    [No Abstract]   [Full Text] [Related]  

  • 12. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.
    Hiatt JR; Carmody IC; Busuttil RW
    J Hepatol; 2005 Oct; 43(4):573-7. PubMed ID: 16112768
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
    Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
    Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver allocation for patients with hepatocellular carcinoma.
    Neuberger J
    Liver Transpl; 2010 Mar; 16(3):249-51. PubMed ID: 20209584
    [No Abstract]   [Full Text] [Related]  

  • 15. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
    Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
    Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
    Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome?
    Belghiti J; Durand F
    Liver Int; 2011 Jan; 31 Suppl 1():161-3. PubMed ID: 21205155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma.
    Kaido T; Takada Y; Uemoto S
    Liver Transpl; 2010 Apr; 16(4):538-40. PubMed ID: 20373466
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
    Pomfret EA; Lodge JP; Villamil FG; Siegler M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S128-32. PubMed ID: 21656657
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?
    Schwartz ME
    Hepatology; 1996 Dec; 24(6):1539-41. PubMed ID: 8938193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.